| 1 |
33660938 | Optimization of dose and route of administration of the P-glycoprotein inhibitor, valspodar (PSC-833) and the P-glycoprotein and breast cancer resistance protein dual-inhibitor, elacridar (GF120918) as dual infusion in rats. | 2021 Apr |
1 |
| 2 |
32344126 | Modulation of nose-to-brain delivery of a P-glycoprotein (MDR1) substrate model drug (quinidine) in rats. | 2020 Jul |
1 |
| 3 |
23852717 | In vitro investigation of amyloid-β hepatobiliary disposition in sandwich-cultured primary rat hepatocytes. | 2013 Oct |
2 |
| 4 |
15799017 | Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833. | 2005 May |
1 |
| 5 |
14980703 | Flavonoid permeability across an in situ model of the blood-brain barrier. | 2004 Mar 1 |
1 |
| 6 |
15025862 | Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat. | 2004 Mar |
2 |
| 7 |
12626638 | Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. | 2003 Jun |
1 |
| 8 |
12920171 | Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A. | 2003 Sep |
1 |
| 9 |
12112443 | Functional expression and localization of P-glycoprotein at the blood brain barrier. | 2002 Jun 1 |
1 |
| 10 |
9751629 | Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein. | 1998 Sep 15 |
1 |